Stockscreener 앱 받기
2.55
3.04%
-0.08
시간 외 거래:
2.52
-0.03
-1.18%
전일 마감가:
$2.63
열려 있는:
$2.62
하루 거래량:
60,352
Relative Volume:
0.07
시가총액:
$3.66M
수익:
$1.03M
순이익/손실:
$-11.10M
주가수익비율:
-0.0386
EPS:
-66.0832
순현금흐름:
$-8.21M
1주 성능:
-4.85%
1개월 성능:
-38.55%
6개월 성능:
-83.56%
1년 성능:
-93.55%
1일 변동 폭
$2.50
$2.735
1주일 범위
$2.50
$2.92
52주 변동 폭
$2.50
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
명칭
Ispecimen Inc
전화
781-301-6700
주소
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.55 | 4.07M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
461.69 | 176.04B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.76 | 128.18B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
546.09 | 44.96B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
124.33 | 36.88B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
357.00 | 35.13B | 3.77B | 449.25M | 240.68M | 7.8556 |
Ispecimen Inc 주식(ISPC)의 최신 뉴스
iSpecimen Q3 2024 Earnings: Significant EPS Miss Amidst Limited Financial DisclosureEarnings Miss Streak - newsline.com
iSpecimen Inc Stock (US46536T1016): shares in focus after quiet session - AD HOC NEWS
ISPC Q3 2024 Earnings: Massive EPS Miss with 983.59% Negative SurpriseAnnual Earnings Summary - newsline.com
ISPC Q3 2024 Earnings: Widely Missed EPS Expectations, Stock Rises 6%Earnings Call Q&A - newsline.com
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - The Globe and Mail
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss with No Reported RevenueFinancial Data - newsline.com
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - TipRanks
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen Inc.Common Stock (Nasdaq:ISPC) Stock Quote - FinancialContent
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss Reflects Operational ChallengesSegment Revenue Breakdown - The Legal Advocate
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - The Legal Advocate
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesHigh Growth Earnings - newsline.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Fast Moving Stocks - The Legal Advocate
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Faces Renewed Selling Pressure, Tests Key Support Near $3.28Safe Entry Stocks - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What is iSpecimen Inc. stock? - Bitget
iSpecimen (NASDAQ: ISPC) posts Q1 2026 loss and warns of going-concern risk - Stock Titan
iSpecimen (NASDAQ: ISPC) notifies SEC of late 10-Q filing - Stock Titan
ISPC Should I Buy - Intellectia AI
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
iSpecimen Raises ~$2.5 Million via Private Placement of Stock and Pre-Funded Warrants - TradingView
iSpecimen (Nasdaq: ISPC) prices $2.5M private placement and regains Nasdaq bid compliance - Stock Titan
iSpecimen raises $2.5M in private placement via E.F. Hutton By Investing.com - Investing.com South Africa
iSpecimen raises $2.5M in private placement via E.F. Hutton - Investing.com
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement - The Manila Times
E.F. Hutton Secures $2.5 Million for iSpecimen - Intellectia AI
TradingKey - TradingKey
iSpecimen announces pricing of approximately $2.5M private placement - MSN
ISpecimen Inc. announced that it has received $2.500004 million in funding - marketscreener.com
iSpecimen prices $2.5M private placement at $5.12 per share By Investing.com - Investing.com Australia
iSpecimen Completes $2.5 Million Private Placement - Intellectia AI
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement - The Manila Times
ISPCiSpecimen Inc. stock news, filings & ratings - Quantisnow
In $2.5M financing, iSpecimen earmarks up to $900,000 for marketing - Stock Titan
iSpecimen Announces $2.5 Million Private Placement Priced at $1.10 Per Share - geneonline.com
Ispecimen Inc (ISPC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.63%
2.88%
자본화:
|
볼륨(24시간):